We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Phase II trial evaluates efficacy and safety of low sodium oxybate for nocturnal cluster headaches, suggesting potential new treatment options.
The www.clinicaltrials.gov identifier is NCT06950281.
No takes yet. Share an insight, caveat, or question.
Liefland et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: